RTW Investments’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,617,626
| Closed | -$20.9M | – | 103 |
|
|
2020
Q3 | $20.9M | Buy |
2,617,626
+17,626
| +0.7% | +$141K | 0.5% | 49 |
|
|
2020
Q2 | $26M | Buy |
+2,600,000
| New | +$26M | 0.73% | 37 |
|
|
2016
Q2 | – | Sell |
-7,691
| Closed | -$63K | – | 35 |
|
|
2016
Q1 | $63K | Buy |
7,691
+636
| +9% | +$5.21K | 0.02% | 31 |
|
|
2015
Q4 | $85K | Buy |
7,055
+27
| +0.4% | +$325 | 0.03% | 34 |
|
|
2015
Q3 | $84K | Sell |
7,028
-12,972
| -65% | -$155K | 0.03% | 39 |
|
|
2015
Q2 | $367K | Buy |
+20,000
| New | +$367K | 0.11% | 29 |
|